KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to -$1.1 billion.

  • BioNTech SE's Cash from Investing Activities fell 593.16% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $805.2 million, marking a year-over-year increase of 113.84%. This contributed to the annual value of -$2.2 billion for FY2024, which is 70.28% up from last year.
  • Per BioNTech SE's latest filing, its Cash from Investing Activities stood at -$1.1 billion for Q3 2025, which was down 1,383.89% from -$72.9 million recorded in Q2 2025.
  • BioNTech SE's 5-year Cash from Investing Activities high stood at $1.3 billion for Q1 2025, and its period low was -$2.9 billion during Q4 2023.
  • In the last 3 years, BioNTech SE's Cash from Investing Activities had a median value of -$789.3 million in 2023 and averaged -$876.4 million.
  • In the last 5 years, BioNTech SE's Cash from Investing Activities spiked by 96,043,443.57% in 2021 and then plummeted by 2,883.12% in 2023.
  • Over the past 5 years, BioNTech SE's Cash from Investing Activities (Quarterly) stood at $114.3 million in 2021, then spiked by 43.73% to $164.3 million in 2022, then plummeted by 1,865.35% to -$2.9 billion in 2023, then surged by 122.36% to $648.3 million in 2024, then crashed by 593.16% to -$1.1 billion in 2025.
  • Its Cash from Investing Activities stands at -$1.1 billion for Q3 2025, versus -$72.9 million for Q2 2025 and $1.3 billion for Q1 2025.